Latest filing published 21 May 2007 for Emergent BioSolutions Inc., €7,693.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -18.1%Entry US$11.17 · Close at T+365 US$9.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas Zink: trading record in brief
All filings by Thomas Zink on record concern Emergent BioSolutions Inc. Over a trading history stretching from 17 May 2007 to 18 May 2007, the count stands at 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €7,769, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 21 May 2007, reports an open-market purchase of €7,693 in Emergent BioSolutions Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas Zink
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 990 shares@ US$10.50Common StockSEC:0001367644-07-000030:0Canonical exit: 16 Aug 2007 (T+90)
- 10 shares@ US$10.30Common StockSEC:0001367644-07-000030:1Canonical exit: 15 Aug 2007 (T+90)
2 of 2 declarations
